| Name | Lepzacitinib |
|---|---|
| Synonyms |
1H-Pyrrolo[2,3-b]pyridine-5-cboxylic acid, 4-[[(3R)-1-(2-cyanoacetyl)-3-piperidinyl]amino]-, ethyl ester
Lzacitinib |
| Description | Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK 1/3[1] |
| References |
| Molecular Formula | C18H21N5O3 |
|---|---|
| Molecular Weight | 355.39 |